Skip to main content
. Author manuscript; available in PMC: 2012 Dec 28.
Published in final edited form as: Med Decis Making. 2011 Jun 14;31(4):540–549. doi: 10.1177/0272989X11408915

Figure 1.

Figure 1

CRC incidence after complete removal of adenomas and preclinical cancers prevalent at age 65, as a percentage of the background incidence (100% – MCLIR65 *); calculations for one cohort of individuals with three models representing the US general population: MISCAN, CRC-SPIN and SimCRC.

*MCLIR = Maximum Clinical Incidence Reduction